SCHEMBL6908941

SCHEMBL6908941

CNC(=S)SC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28754503 0.97
SCHEMBL20213699 0.97
Ammonia Solution, Strong SCHEMBL11721962 0.97
SCHEMBL27898533 0.97
SCHEMBL29242362 0.97
SCHEMBL22471733 0.97
SCHEMBL20601185 0.97
Dimethylamine SCHEMBL20601195 0.97
SCHEMBL22227625 0.97
SCHEMBL27395526 0.97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030176496-A1 Administering an antiproliferative agent in combination with a potentiating effective amount of a N- substituted dithiocarbamate ester or a pharmaceutically acceptable salt thereof ATHEROGENICS, INC. (US) 2003-09-18 US claimed
EP-0949265-B1 RADIOACTIVE TRANSITION METAL NITRIDE HETERO-COMPLEX NIHON MEDIPHYSICS CO LTD (JP) 2003-05-07 EP claimed
EP-1282445-A2 N-SUBSTITUTED DITHIOCARBAMATES FOR THE TREATMENT OF BIOLOGICAL DISORDERS Atherogenics, Inc. (US) 2003-02-12 EP claimed
US-20020048549-A1 Radioactive transition metal nitride heterocomplex DUATTI ADRIANO (IT) 2002-04-25 US claimed
WO-2001079164-A2 N-SUBSTITUTED DITHIOCARBAMATES FOR THE TREATMENT OF BIOLOGICAL DISORDERS ATHEROGENICS, INC. (US) 2001-10-25 WO claimed
US-6270745-B1 FROM A BIS(PHOSPHINOALKYL) SULFIDE OR AMINE NIHON MEDI-PHYSICS CO., LTD. (JP) 2001-08-07 US claimed
EP-0949265-A1 RADIOACTIVE TRANSITION METAL NITRIDE HETERO-COMPLEX Nihon Medi-Physics Co., Ltd. (JP) 1999-10-13 EP claimed
US-20240018378-A1 UV-VIS RADIATION CURABLE SECURITY INKS FOR PRODUCING DICHROIC SECURITY FEATURES SICPA HOLDING SA (CH) 2024-01-18 US disclosed
CN-117209450-A Chemical synthesis method of diaminophenothiazinium compound including methyl sulfonium chloride (MTC) 维斯塔实验室有限公司 2023-12-12 CN disclosed
CN-110092764-B Chemical synthesis method of diaminophenothiazinium compound including methyl sulfonium chloride (MTC) 维斯塔实验室有限公司 2023-09-15 CN disclosed
US-11690915-B2 Ras inhibitors Revolution Medicines, Inc. (US) 2023-07-04 US disclosed
CN-114874499-B Graphene oxide loaded rare earth vulcanization accelerator and preparation method thereof 北京化工大学 2023-05-26 CN disclosed
EP-4130136-A1 RUBBER COMPOSITION, VULCANIZED MATERIAL, AND MOLDED ARTICLE Denka Company Limited (JP) 2023-02-08 EP disclosed
EP-0949265-A1 RADIOACTIVE TRANSITION METAL NITRIDE HETERO-COMPLEX Nihon Medi-Physics Co., Ltd. (JP) 1999-10-13 EP disclosed
EP-0791582-A1 INDOLE-2-CARBOXYLIC ESTER DERIVATIVES AND AGRICULTURAL AND HORTICULTURAL BACTERIOCIDES CONTAINING THE SAME AS THE ACTIVE INGREDIENT OTSUKA KAGAKU KABUSHIKI KAISHA (JP) 1997-08-27 EP disclosed
CN-1034331-C Amines and their use MITSUI PHARMACEUTICALS LTD (JP) 1997-03-26 CN disclosed
CN-1139387-A Composition and process for reducing or preventing metal and acid contamination in rock drainage BUCKMAN LABOR INC (US) 1997-01-01 CN disclosed
US-4372963-A HISTAMINE ANTAGONISTS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1983-02-08 US disclosed
US-4285952-A Pyridyl, thiazolyl and isothiazolyl alkyl bisamidines SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1981-08-25 US disclosed
US-4212875-A ANTIHISTAMINES SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1980-07-15 US disclosed